Did I Meet My 2015 Goals?
It is hard to believe that it is 2016 already!
Let’s see how I did in achieving my goals for 2015:
To review in more detail my goals for 2015, please visit the post here: Scott’s Goals for 2015
1) Max Roth IRA ($5,500) as soon as possible – Pass
The final contribution into my Roth IRA happened on March 9th. While this wasn’t as early as previous years, I still count this as a pass. Contributing as early as possible , I feel, is important in order to achieve the best long-term results.
2) Generate at least $4,100 a year in dividends – Pass
I was excited to beat this goal by receiving $4308 this year. In fact, in 2015 I averaged $359 per month, nearly what it took me all year in 2011 to achieve ($379)! Will there be another 10-fold increase over the next 4 years? $43,000 a year? Probably not since that would require a portfolio worth over $1.4 million at 3%!
3) Invest more in low yielding but higher growth stocks – Pass
While I didn’t invest as much in the low-dividend high-growth category as I was hoping, I did make a number of purchases. I invested a total of $675 in Disney and $1616 in Visa in the year 2015. Combined with additional purchases in previous years, I hold $1000 of Disney and $9,983 of Visa. I also own $23,000 worth of Apple. Disney has a yield of 1.35%, Apple of 1.98%, and Visa only of 0.72%. My yield-on-cost in Visa is actually up to 1.08% thanks to its excellent dividend growth. I would have invested more in these kind of companies, but the way 2015 played out there were too many higher yielding stocks that had dropped in price that I was able to pick up at a discount.
4) Invest in biotech/ immunotherapy companies – Pass
In addition to the Johnson & Johnson that I own, I also purchased a couple of companies that are focusing more on immunotherapy and targeted treatments. In 2015 I purchased $5400 worth of Amgen, a biotechnology company that pays a great dividend (2.46%) and has been raising it significantly in recent years. It doesn’t have the aristocrat status that JNJ has but is on its way to achieving that. My second and more risky biotechnology purchase is a much smaller company called Inovio Pharmaceuticals. I put about $2050 into INO. INO does not pay a dividend; I’m holding this solely for capital appreciation.
5) Improve Two Investing content – Pass
At least I think so. Other than Johnny not contributing a single post (come on Johnny!!), I was fairly active in writing at least a couple articles a month. I am also very proud of the literally hours and hours (I’m not joking) that I have been putting in to making my dividend investing Google spreadsheets. I also released a separate international version. I’m working on some exciting updates to them for 2016! (More details soon).
I feel pretty confident in saying that I exceeded these goals. In the future, I’ll have to try to place more reach goals or ones that are difficult to achieve. I thought the $4100 in annual dividends was a stretch, but I blew by that! I might try and check my progress 6 months into the year to update the goals if needed.
How was your 2015? Did you meet your investing and personal goals?